It is vital to correctly evaluate the pancreatic function of patients with diabetes to protect the residual pancreatic function through appropriate therapy, whereas whether BMI has different degrees of impact on insulin secretion in different levels of blood glucose as the FBG increases is still unclear. The gene discussed is INS; the disease is diabetes mellitus.